HCmed Innovations Co., Ltd. (TPE:6934)

HCmed Innovations Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	168.89	138.55	65.83	66.61	123.5	48.49
Short-Term Investments	255	125	110	177	-	-
Cash & Short-Term Investments	423.89	263.55	175.83	243.61	123.5	48.49
Cash Growth	58.54%	49.89%	-27.83%	97.26%	154.69%	-43.59%
Accounts Receivable	7.79	6.38	1.47	0.29	0.38	0.1
Other Receivables	1.34	0.49	0.22	0.05	-	0.04
Receivables	9.14	6.87	1.7	0.34	0.38	0.13
Inventory	33.56	13.65	5.56	5.91	5.39	11.49
Prepaid Expenses	5.58	3.49	4.28	4.67	2.76	1.01
Other Current Assets	-	0.01	0	-	-	0
Total Current Assets	472.16	287.56	187.36	254.54	132.03	61.13
Property, Plant & Equipment	184.33	139.77	28.72	32.23	14.49	19.58
Long-Term Investments	-	-	-	-	-	6.59
Goodwill	-	-	-	12.16	35.49	-
Other Intangible Assets	1.19	1.23	13.9	20.37	22.61	0.05
Other Long-Term Assets	10.01	12.63	16.81	6.79	2.01	1.81
Total Assets	667.69	441.19	246.79	326.08	206.62	89.15

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	10.8	6.93	1.25	0.72	1.24	0
Accrued Expenses	-	28.35	17.71	14.59	11.04	9.53
Current Portion of Long-Term Debt	-	1.96	-	-	-	-
Current Portion of Leases	16.33	16	6.71	11.81	2.72	5.74
Current Unearned Revenue	-	-	0.95	9.01	-	-
Other Current Liabilities	24.83	6.54	6.12	4.45	5.25	4.35
Total Current Liabilities	51.96	59.77	32.74	40.58	20.25	19.61
Long-Term Debt	41.09	42.09	-	-	-	-
Long-Term Leases	45.07	51.9	2.13	4.44	0.88	3.41
Long-Term Deferred Tax Liabilities	-	-	2.6	4.05	4.52	-
Other Long-Term Liabilities	-	-	-	-	-	238.45
Total Liabilities	138.12	153.76	37.48	49.07	25.65	261.47

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	361.3	327.17	300.34	300.11	244.11	175.31
Additional Paid-In Capital	-	624.15	446.76	436.87	230.73	5.69
Retained Earnings	-759.55	-664.12	-538.01	-459.79	-293.87	-366.97
Comprehensive Income & Other	927.82	0.23	0.23	-0.17	-	13.64
Shareholders' Equity	529.57	287.43	209.31	277.01	180.97	-172.32
Total Liabilities & Equity	667.69	441.19	246.79	326.08	206.62	89.15

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	102.49	111.95	8.84	16.25	3.6	9.15
Net Cash (Debt)	321.4	151.6	166.99	227.37	119.9	39.34
Net Cash Growth	47.40%	-9.21%	-26.55%	89.63%	204.77%	-53.13%
Net Cash Per Share	9.43	4.72	5.56	8.56	5.55	2.24
Filing Date Shares Outstanding	35.99	32.72	30.03	30.01	24.41	25.63
Total Common Shares Outstanding	35.99	32.72	30.03	30.01	24.41	17.53
Working Capital	420.2	227.79	154.62	213.96	111.78	41.52
Book Value Per Share	14.71	8.79	6.97	9.23	7.41	-9.83
Tangible Book Value	528.38	286.2	195.41	244.49	122.88	-172.38
Tangible Book Value Per Share	14.68	8.75	6.51	8.15	5.03	-9.83
Land	-	31.13	-	-	-	-
Buildings	-	25.59	-	-	-	-
Machinery	-	49.94	44.42	34.2	25.59	19.95
Construction In Progress	-	-	-	0.55	0.3	-
Leasehold Improvements	-	12.74	12.32	12.04	7.2	6.19

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error